MedPath

Effects of ashwagandha in advanced cancer patients

Not Applicable
Conditions
Health Condition 1: null- 50 hemodynamically stable stage IV cancer patients with or without chemotherapy shall be given the coded trial medicine or placebo
Registration Number
CTRI/2013/05/003688
Lead Sponsor
Vir Chandra Singh Garhwali Government Institute of Medical Sciences and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

1.Patient admitted in oncology ward or OPD patients of Base Hospital, Srikot, Pauri-Garhwal, Uttarakhand for chemotherapy or palliation

2.Stage IV clinically and heamodynamically stable, cancer patient willing to participate and give informed consent in the trial

3.Age group:18-60 yrs

4.Either gender

Exclusion Criteria

1.Age <18yrs or >60 yrs

2.Stage I,II,III cancer patients

3.Clinically and heamodynamically unstable patients

4.Patients receiving any other alternative therapies(ayurveda/homeopathic/herbal/dietary suppliments)

5.Patient receiving G-CSF

6.Patient receiving radiotherapy

7.Acute medical or surgical complications that require hospitalization

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath